BioNTech

BNTX

Market cap $23.3B

BNTX Hedge Fund Activity: Q1 2026 in Review

272 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q1 2026, worth a combined $4.22B — down 7.4% from $4.56B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of BNTX and 41 opened new positions — a net loss of 9 holders — while 74 trimmed existing stakes and 92 added.

The largest buyer was T. Rowe Price Investment Management, adding an estimated $141M. The largest seller was Capital International Investors, exiting entirely with an estimated $108M sold.

• 272 institutional investors held BioNTech (BNTX) as of Q1 2026, down from 284 in Q4 2025.
• Funds reported $4.22B of BioNTech stock for Q1 2026, down 7.4% quarter-over-quarter.
• 41 funds opened new BioNTech positions in Q1 2026 and 50 closed out, a net change of -9 holders.
• The largest BioNTech buyer in Q1 2026 was T. Rowe Price Investment Management, an estimated $141M added.
• The largest BioNTech seller in Q1 2026 was Capital International Investors, an estimated $108M sold.

Based on aggregated 13F filings for Q1 2026.